Abiopharma

News list

JAIN ABHINAV 🟢 acquired 29.9K shares (1 derivative) of TALPHERA, INC. (TLPH) at $1.14 Transaction Date: Oct 23, 2025 | Filing ID: 000006

Full text

News bot Oct. 24, 2025, 8:42 p.m.
🔍 JAIN ABHINAV (Executive)

Company: TALPHERA, INC. (TLPH)

Report Date: 2025-10-23
Transaction Summary:
- Total transactions: 2
- Derivative instruments: 1
- Holdings reported: 0
- Total shares acquired: 29,867
Detailed Transactions and Holdings:
- Acquired 4,267 shares of Common Stock (Direct)
  Date: 2025-10-23 | Code: A | equity_swap_involved: 0 | shares_owned_after: 7,312.00 | transaction_form_type: 4 | Footnotes: F1, F2
- Acquired 25,600 shares of Stock Option (Right to Buy) at $1.14 per share (Derivative)
  Date: 2025-10-23 | Code: A | Expires: 2035-10-22 | equity_swap_involved: 0 | shares_owned_after: 25,600.00 | transaction_form_type: 4 | Footnotes: F3
Footnotes:
- F1: Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock.
- F2: 100% of the restricted stock units shall vest on the first anniversary of the grant date, subject to Reporting Person's continuous service to the Company.
- F3: 100% of the shares subject to the option shall vest on the one-year anniversary of the grant date, subject to the Reporting Person's continuous service to the Company.